Wave Life Sciences Ltd.
WVE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $8 | $9 | $9 | $84 |
| % Growth | -12.5% | -5.2% | -89% | – |
| Cost of Goods Sold | $0 | $2 | $2 | $0 |
| Gross Profit | $8 | $7 | $7 | $84 |
| % Margin | 100% | 74.8% | 76.4% | 100% |
| R&D Expenses | $46 | $43 | $41 | $45 |
| G&A Expenses | $18 | $18 | $18 | $16 |
| SG&A Expenses | $18 | $18 | $18 | $16 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$2 | -$2 | $0 |
| Operating Expenses | $64 | $59 | $57 | $61 |
| Operating Income | -$56 | -$53 | -$50 | $23 |
| % Margin | -740.7% | -606.5% | -542.8% | 27.4% |
| Other Income/Exp. Net | $3 | $2 | $3 | $6 |
| Pre-Tax Income | -$54 | -$50 | -$47 | $29 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$54 | -$50 | -$47 | $29 |
| % Margin | -707.8% | -580.2% | -510.9% | 34.9% |
| EPS | -0.32 | -0.31 | -0.29 | 0.18 |
| % Growth | -3.2% | -6.9% | -261.1% | – |
| EPS Diluted | -0.32 | -0.31 | -0.29 | 0.17 |
| Weighted Avg Shares Out | 168 | 164 | 163 | 161 |
| Weighted Avg Shares Out Dil | 168 | 164 | 163 | 172 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $2 | $3 | $4 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $2 | $2 | $2 | $2 |
| EBITDA | -$52 | -$51 | -$48 | $25 |
| % Margin | -678.5% | -581.3% | -519.2% | 30% |